Poisons, Opium and Dangerous Drugs (Amendment) Act, No. 41 of 2022

PARLIAMENT OF THE DEMOCRATIC SOCIALIST REPUBLIC OF SRI LANKA PRINTED AT THE DEPARTMENT OF GOVERNMENT PRINTING, SRI LANKA TO BE PURCHASED AT THE GOVERNMENT PUBLICATIONS BUREAU, COLOMBO 5 Price : Rs. 60.00 Postage : Rs. 35.00 Published as a Supplement to Part II of the Gazette of the Democratic Socialist Republic of Sri Lanka of November 25, 2022 This Act can be downloaded from www.documents.gov.lk Printed on the Order of Government [Certified on 23rd of November, 2022] POISONS, OPIUM AND DANGEROUS DRUGS (AMENDMENT) ACT, No. 41 OF 2022 1Poisons, Opium and Dangerous Drugs (Amendment) Act, No. 41 of 2022 L.D.–O. 5/2021 AN ACT TO AMEND THE POISONS, OPIUM AND DANGEROUS DRUGS ORDINANCE (CHAPTER 218) BE it enacted by the Parliament of the Democratic Socialist Republic of Sri Lanka as follows: 1. This Act may be cited as the Poisons, Opium and Dangerous Drugs (Amendment) Act, No. 41 of 2022. 2. Section 54A of the Poisons, Opium and Dangerous Drugs Ordinance (Chapter 218) (hereinafter referred to as the “principal enactment”) is hereby amended as follows: (1) by the re-numbering of section 54A as subsection (1) of that section; (2) in the renumbered subsection (1), by the repeal of all the words from “In this section: -” to the end of that section; (3) by the insertion immediately after subsection (1), of the following new subsections: “(2) In any proceedings under subsection (1), a certificate signed by an authorized analyst confirming (a) the type of the dangerous drug; and (b) that the gross weight of such dangerous drug is two grammes or less, shall be prima facie evidence of the facts stated therein and the pure quantity of such dangerous drug shall be deemed to be not exceeding two grammes. Short title Amendment of section 54A of Chapter 218 [Certified on 23rd of November, 2022] 2 Poisons, Opium and Dangerous Drugs (Amendment) Act, No. 41 of 2022 (3) In this section “Goverment Analyst” means the person holding office as the Goverment Analyst for the time being and includes an Additional, Deputy, Senior Assistant or Assistant Government Analyst and any person appointed to act as the Government Analyst or an Additional, Deputy, Senior Assistant or Assistant Government Analyst; “manufacture” in relation to a dangerous drug includes any process of producing such drug and the refining or transformation of one drug into another; “traffick” means (a) to sell, give, procure, store, administer, transport, send, deliver or distribute; or (b) to offer to do anything specified in paragraph (a).”. 3. Section 77A of the principal enactment is hereby amended as follows: (1) by the repeal of subsections (2), (3) and (4) of that section and the substitution therefor of the following: “(2) Where the Government Analyst has made an examination of any drug, substance, article or preparation submitted to him under Amendment of section 77A of the principal enactment 3Poisons, Opium and Dangerous Drugs (Amendment) Act, No. 41 of 2022 subsection (1), he shall, within a period not exceeding twelve months from the date of such submission, send a report setting out the result of his examination to the Magistrate or any other competent court which has the jurisdiction to try an offence committed under Chapter III or Chapter V of this Ordinance, with copies to the police officer who submitted such drug, substance, article and preparation or any portion or sample for examination and to the Police Narcotics Bureau. (3) A report submitted to the Magistrate or any other competent court under subsection (2) shall be prima facie evidence in any inquiry, trial or other proceeding conducted under this Ordinance. (4) Where any person raises an issue in respect of the opinion of the Government Analyst specified in the report referred to in subsection (3) in any inquiry, trial or other proceeding, the burden of proving the fact that such report is inaccurate shall lie on the person who raises such issue.”. (2) by the addition immediately after subsection (4) of that section, of the following: “(5) (a) Where the Magistrate or the judge of any competent court having the jurisdiction to try the offence committed under Chapter III or Chapter V, is of the opinion that such drug, substance, article or preparation would become necessary in evidence during the proceedings before such court in respect of any offence, he shall order the Police Narcotics Bureau or any person authorized by the Magistrate or the Judge of such competent court to photograph such 4 Poisons, Opium and Dangerous Drugs (Amendment) Act, No. 41 of 2022 drug, substance, article or preparation, including the packages and seals, and to preserve the necessary evidance including packages and seals and to order the Police Narcotics Bureau or any person authorized by the Magistrate or the Judge of such competent court to destroy the same in the presence of the Registrar of such court, the prosecuting Counsel or the Police Officer who conducts the prosecution or his representative and the defence Counsel or his representative. (b) The Police Narcotics Bureau or the person authorized by the Magistrate or the judge of the competent court, as the case may be, shall take the photographs in terms of the order made under paragraph (a) and forward such photographs and the necessary evidence including packages and seals forthwith to the relevant court. (c) The Police Narcotics Bureau or any person authorized by the Magistrate or the judge of such competent court shall under the supervision of the Magistrate or the judge of the competent court, as the case may be, destroy or cause to be destroyed such drug, substance, article or preparation in compliance with the order made by such Magistrate or the judge as the case may be, under paragraph (a) within a period of two months of the date of such order and shall forthwith submit a report relating to such destruction to the relevant court. (6) The Minister assigned the subject of Justice may, with the concurrence of the Judicial Service Commission prescribe by regulation, the mechanism of disposal of such drug, substance, article or preparation specified in subsection (5).”. 5Poisons, Opium and Dangerous Drugs (Amendment) Act, No. 41 of 2022 4. Section 83 of the principal enactment is hereby repealed and the following section is substituted therefor: 83. (1) Subject to the provisions of sections 84, 85 and subsection (2) of this section, a person suspected or accused of an offence under sections 54A and 54B of this Ordinance, shall not be released on bail by the High Court except in exceptional circumstances. (2) Notwithstanding the provisions of sections 84 and 85, a person suspected or accused of an offence under subsection (1) of section 54A and section 54B (a) of which the pure quantity of the dangerous drug, trafficked, imported, exported or possessed is ten grammes or above in terms of the report issued by the Government Analyst under section 77A ; and (b) which is punishable with death or life imprisoment, shall not be released on bail except by the Court of Appeal in exceptional circumstances. (3) For the purposes of this section “dangerous drug” means Morphine, Cocaine, Heroin and Methamphetamine.”. 5. The following new sections are hereby inserted immediately after section 83 of the principal enactment, and shall have effect as sections 84, 85, 86 and 87 of that enactment : Replacement of section 83 of the principal enactment “No bail for an offence under sections 54A and 54B except in exceptional circumstances Insertion of new sections 84, 85, 86 and 87 in the principal enactment 6 Poisons, Opium and Dangerous Drugs (Amendment) Act, No. 41 of 2022 84. A suspect or an accused who has not been tried and has not been convicted and sentenced by a Court under the provisions of subsection (1) of section 54A and section 54B, shall not be detained in custody for a period exceeding twelve months from the date of his arrest. 85. Notwithstanding the provisions of section 84, on application made in that behalf by the Attorney-General to the High Court established under Article 105 or a High Court established by Article 154P of the Constitution such court may, for good and sufficient reasons that shall be recorded, order that a suspect or an accused who has not been tried and has not been convicted and sentenced by a Court under the provisions of subsection (1) of section 54A and section 54B, be detained in custody for a period in excess of twelve months: Provided that, the period of detention ordered under this section, shall not in any case exceed three months at a time and twenty four months in the aggregate. 86. (1) A person who is alleged to have committed an offence under section 52, section 54 or paragraphs (b), (c) or (d) of subsection (1) of section 54A (in this section referred to as the “offender”) shall not be liable for prosecution for an offence under the said provision in the following circumstances: (a) where the quantity of the dangerous drug involved in the commission of the offence is less than one gramme; “No person to be detained for more than twelve months in custody Extension of the period of detention Voluntary admission to medical treatment for de-addiction and rehabilitation 7Poisons, Opium and Dangerous Drugs (Amendment) Act, No. 41 of 2022 (b) where such person seeks to undergo medical treatment for de-addiction and rehabilitation; and (c) where the Attorney-General has sanctioned the staying of the prosecution. (2) (a) The Officer-in- Charge of the relevant Police Station, who conducts the investigation on the offender shall refer the offender to be examined by a Government Medical Officer to obtain a medical report on the extent of the drug dependency of such person. (b) If the medical report obtained under paragraph (a) confirms that the offender is a drug dependent person, the Officer-in-Charge of the Police Station shall refer such person to residential or non-residential treatment or rehabilitation in a Treatment and Rehabilitation Centre designated in terms of the Drug Dependent Persons (Treatment and Rehabilitation) Act, No. 54 of 2007. (3) Notwithstanding the preceding provisions of this section, any offender who fails to complete the treatment referred to in paragraph (b) of subsection (2) shall be liable to be prosecuted under section 52, section 54 or subsection (1) of section 54A, as the case may be. 87. Any person under the age of eighteen years who commits an offence punishable with death or life imprisonment under section 52, section 54, paragraphs (b), (c) and (d) of subsection (1) of section 54A and 54B shall not be punished with death or life imprisonment and shall only be liable for imprisonment for a term not exceeding ten years with compulsory rehabilitation and five years probation under the Probation of Offenders Ordinance (Chapter 23).”. Probation for young offenders under eighteen years of age 8 Poisons, Opium and Dangerous Drugs (Amendment) Act, No. 41 of 2022 Amendment of the Third Schedule to the principal enactment “GROUP B (sections 48, 51 and 68) Drugs, substances, articles or preparations to which the provisions as to importation, exportation and wholesale and retail trade apply. SECTION 1 1 Acetorphine 3-O-acetyltetrahydro-7α-(1-hydroxy-1 methylbutyl)-6,14-endo ethenooripavine (derivative of thebaine) 2 Acetyl-alpha- N-[1-(α-methylphenethyl)-4 methylfentanyl piperidyl]acetanilide 3 Acetylfentanyl N-Phenyl-N-[1-(2-phenylethyl)-4 piperidinyl]acetamide 4 Acetylmethadol 3-acetoxy-6-dimethylamino-4,4 diphenylheptane 5 Acryloylfentanyl N-phenyl-N-[1-(2- phenylethyl) (acrylfentanyl) piperidin-4-yl] prop- 2-enamide 6 Alfentanil N-[1-[2-(4-ethyl-4,5-dihydro-5 oxo-1H-tetrazol-1-yl)ethyl]-4 (methoxymethyl)-4-piperidinyl] N-phenylpropanamide 7 AH-7921 3,4-Dichloro-N-{[1-(dimethylamino) cyclohexyl] methyl}benzamide 8 Allylprodine 3-allyl-1-methyl-4-phenyl-4 propionoxypiperidine 9 Alphacetyl α-3-acetoxy-6-dimethylamino methadol 4,4-diphenylheptane 10 Alphameprodine α-3-ethyl-1-methyl-4-phenyl-4 propionoxypiperidine 11 Alphamethadol α-6-dimethylamino-4,4 diphenyl 3-heptanol 12 Alpha- N-[1-(α-methylphenethyl)-4 Methylfentanyl piperidyl]propionanilide 6. The Third Schedule to the principal enactment is hereby amended as follows: (1) by the substitution, for Group B of Part I of that Schedule, of the following: 9Poisons, Opium and Dangerous Drugs (Amendment) Act, No. 41 of 2022 13 Alpha Methylthiofentanyl N-[1-[1-methyl-2-(2 thienyl)ethyl]-4 piperidyl]propionanilide 14 Alphaprodine α-1,3-dimethyl-4-phenyl-4 propionoxypiperidine 15 Anileridine 1-p-aminophenethyl-4 phenylpiperidine-4-carboxylic acid ethyl ester 16 Benzethidine 1-(2-benzyloxyethyl)-4 phenylpiperidine-4-carboxylic acid ethyl ester 17 Benzylmorphine 3-benzylmorphine 18 Betacetylmethadol -3-acetoxy-6-dimethylamino 4,4-diphenylheptane 19 beta-Hydroxyfentanyl N-[1-( -hydroxyphenethyl)-4 piperidyl] propionanilide 20 beta-Hydroxy-3- N - [ 1 - ( - h y d r o x y p h e n e t h y l ) - 3 methylfentanyl methyl-4-piperidyl]propionanilide 21 Betameprodine -3-ethyl-1-methyl-4-phenyl-4 propionoxypiperidine 22 Betamethadol -6-dimethylamino-4,4-diphenyl 3-heptanol 23 Betaprodine -1,3-dimethyl-4-phenyl-4 propionoxypiperidine 24 Bezitramide 1-(3-cyano-3,3-diphenylpropyl)-4-(2 oxo-3-propionyl-1-benzimidazolinyl) piperidine 25 Butyrfentanyl N-phenyl-N-[1-(2-phenylethyl)-4 piperidinyl]butanamide 26 Cannabis the flowering or fruiting tops of the cannabis plant (resin not extracted) 27 Cannabis Resin, the separated resin, crude or purified, Extracts and obtained from the cannabis plant Tinctures 28 Carfentanil Methyl 1-(2-phenylethyl)-4 [phenyl (propanoyl) amino] piperidine- 4- carboxylate 29 Clonitazene 2-(p-chlorobenzyl)-1 diethylaminoethyl-5 nitrobenzimidazole â â â â â â 10 Poisons, Opium and Dangerous Drugs (Amendment) Act, No. 41 of 2022 30 Coca leaf the leaf of the coca bush (plant material), except a leaf from which all ecgonine, cocaine and any other ecgonine alkaloids have been removed 31 Cocaine methyl ester of benzoylecgonine (an alkaloid found in coca leaves or prepared by synthesis from ecgonine) 32 Codoxime dihydrocodeinone-6 carboxymethyloxime (derivate of morphine) 33 Concentrate of The material arising when parts of poppy straw any plant of the species Papaversomniferum have entered a process for the concentration of the alkaloids 34 Cyclopropylfentanyl N-Phenyl-N-[1-(2-phenylethyl) piperidin-4- yl] cyclopropanecarboxamide 35 Desomorphine Dihydrodesoxymorphine (derivative of morphine) 36 Dextromoramide (+)-4-[2-methyl-4-oxo-3,3 diphenyl-4-(1-pyrrolidinyl) butyl] morpholine (dextro-rotatory isomer of moramide) 37 Diampromide N-[2-(methylphenethylamino) propyl] propionanilide 38 Diethylthiambutene 3-diethylamino-1,1-di-(2’ thienyl)-1-butene 39 Difenoxin 1-(3-cyano-3,3-diphenylpropyl) 4-phenylisonipecotic acid 40 Dihydroetorphine 7,8-dihydro-7α-[1-(R)-hydroxy-1 methylbutyl]-6,14-endo ethanotetrahydrooripavine (derivative of etorphine) 41 Dihydromorphine (derivative of morphine) 42 Dimenoxadol 2-dimethylaminoethyl-1-ethoxy 1,1-diphenylacetate 43 Dimepheptanol 6-dimethylamino-4,4-diphenyl-3 heptanol 44 Dimethylthiambutene 3-dimethylamino-1,1-di-(2’-thienyl) 1-butene 11Poisons, Opium and Dangerous Drugs (Amendment) Act, No. 41 of 2022 45 Dioxaphetyl ethyl-4-morpholino-2,2 butyrate diphenylbutyrate 46 Diphenoxylate 1-(3-cyano-3,3-diphenylpropyl)-4 phenylpiperidine-4-carboxylic acid ethyl ester 47 Dipipanone 4,4-diphenyl-6-piperidine-3-heptanone 48 Drotebanol 3,4-dimethoxy-17 methylmorphinan-6 ,14-diol 49 Ecgonine its esters and derivatives which are convertible to ecgonine and cocaine 50 Ethylmethylthiambutene 3-ethylmethylamino-1,1-di-(2’ thienyl)-1-butene 51 Etonitazene 1-diethylaminoethyl-2-p ethoxybenzyl-5 nitrobenzimidazole 52 Etorphine tetrahydro-7α-(1-hydroxy-1 methylbutyl)-6,14-endo ethenooripavine (derivative of thebaine) 53 Etoxeridine 1-[2-(2-hydroxyethoxy)-ethyl]-4 phenylpiperidine-4-carboxylic acid ethyl ester 54 Fentanyl 1-phenethyl-4-N propionylanilinopiperidine 55 4-Fluoroisobutyrfentanyl N-(4-fluorophenyl)-N-(1 (4- FIBF, pFIBF) phenetylpiperidin-4-yl)isobutyramide 56 Furanylfentanyl N-phenyl-N-[1-(2 phenylethyl)piperidin-4-yl]furan 2-carboxamide 57 Furethidine 1-(2-tetrahydrofurfuryloxyethyl)-4 phenylpiperidine-4-carboxylic acid ethyl ester 58 Heroin Diacetylmorphine 59 Hydrocodone Dihydrocodeinone 60 Hydromorphinol 14-hydroxydihydromorphine (derivative of morphine) 61 Hydromorphone dihydromorphinone (derivative of morphine) 62 Hydroxypethidine 4-m-hydroxyphenyl-1 methylpiperidine-4-carboxylic acid ethyl ester â 12 Poisons, Opium and Dangerous Drugs (Amendment) Act, No. 41 of 2022 63 Isomethadone 6-dimethylamino-5-methyl-4,4 diphenyl-3-hexanone 64 Ketobemidone 4-m-hydroxyphenyl-1-methyl-4 propionylpiperidine 65 Levomethorphan (-)-3-methoxy-N methylmorphinan 66 Levomoramide (-)-4-[2-methyl-4-oxo-3,3 diphenyl-4-(1 pyrrolidinyl)butyl]morpholine 67 Levophenacylmorphan (-)-3-hydroxy-N phenacylmorphinan 68 Levorphanol (-)-3-hydroxy-N methylmorphinan 69 Metazocine 2-hydroxy-2,5,9-trimethyl-6,7 benzomorphan 70 Methadone 6-dimethylamino-4,4-diphenyl-3 heptanone 71 Methadone 4-cyano-2-dimethylamino-4,4 Intermediate diphenylbutane 72 Methoxyacetyl 2-Methoxy-N-phenyl-N-[1-(2 fentanyl phenylethyl)piperidin-4-yl] acetamide 73 Methyldesorphine 6-methyl- -deoxymorphine (derivative of morphine) 74 Methyldihyd 6-methyldihydromorphine romorphine (derivative of morphine) 75 3-Methylfentanyl N-(3-methyl-1-phenethyl-4 piperidyl)propionanilide 76 3-Methylthio N-[3-methyl-1-[2-(2 fentanyl thienyl) ethyl]-4 piperidyl]propionanilide 77 Metopon 5-methyldihydromorphinone (derivative of morphine) 78 Moramide 2-methyl-3 Intermediate morpholino-1,1-diphenylpropane carboxylic acid 79 Morpheridine 1-(2-morpholinoethyl)-4 phenylpiperidine-4-carboxylic acid ethyl ester 80 Morphine the principal alkaloid of opium and of opium poppy 6 13Poisons, Opium and Dangerous Drugs (Amendment) Act, No. 41 of 2022 81 Morphine any other pentavalent Methobromide nitrogen morphinederivatives including in particular the morphine-N-oxide derivatives, one of which is codeine-N-oxide 82 Morphine-N-oxide A derivate of morphine 83 MPPP 1-methyl-4-phenyl-4-piperidinol propionate (ester) 84 MT-45 1-cyclohexyl-4-(1,2-diphenylethyl) piperazine 85 Myrophine Myristylbenzylmorphine (derivate of morphine) 86 Nicomorphine 3,6-dinicotinylmorphine (derivate of morphine) 87 Noracymethadol (±)-α-3-acetoxy-6-methylamino 4,4-diphenylheptane 88 Norlevorphanol (-)-3-hydroxymorphinan 89 Normethadone 6-dimethylamino-4,4-diphenyl-3 hexanone 90 Normorphine demethylmorphine (derivate of morphine) 91 Norpipanone 4,4-diphenyl-6-piperidino-3 hexanone 92 Ocfentanil N-(2-fluorophenyl)-2-methoxy-N [1-(2-phenylethyl)piperidin-4-yl] acetamide 93 Opium The coagulated juice of the opium poppy plant species Papaversomniferum L. 94 Oripavine 3-O-demethylthebaine 95 Orthofluorofentanyl N-(2-Fluorophenyl)-N [1-(2-phenylethyl)piperidin-4-yl] propanamide 96 Oxycodone 14-hydroxydihydrocodeinone (derivate of morphine) 97 Oxymorphone 14-hydroxydihydromorphinone (derivate of morphine) 98 Parafluorobutyryl N-(4-Fluorophenyl)-N fentanyl [1-(2-phenylethyl)piperidin-4-yl] butanamide 99 para-Fluorofentanyl 4’-fluoro-N-(1-phenethyl-4 piperidyl)propionanilide 14 Poisons, Opium and Dangerous Drugs (Amendment) Act, No. 41 of 2022 100 PEPAP 1-phenethyl-4-phenyl-4 piperidinol acetate (ester) 101 Pethidine 1-methyl-4-phenylpiperidine-4 carboxylic acid ethyl ester 102 Pethidine 4-cyano-1-methyl-4 Intermediate A phenylpiperidine 103 Pethidine 4-phenylpiperidine-4 Intermediate B carboxylic acid ethyl ester 104 Pethidine 1-methyl-4-phenylpiperidine Intermediate C -4-carboxylic acid 105 Phenadoxone 6-morpholino-4,4-diphenyl-3 heptanone 106 Phenampromide N-(1-methyl-2 piperidinoethyl)propionanilide 107 Phenazocine 2’-hydroxy-5,9-dimethyl-2 phenethyl-6,7-benzomorphan 108 Phenomorphan 3-hydroxy-N phenethylmorphinan 109 Phenoperidine 1-(3-hydroxy-3-phenylpropyl)-4 phenylpiperidine-4-carboxylic acid ethyl ester 110 Piminodine 4-phenyl-1-(3 phenylaminopropyl)piperidine-4 carboxylic acid ethyl ester 111 Piritramide 1-(3-cyano-3,3-diphenylpropyl) 4-(1-piperidino)piperidine-4 carboxylic acid amide 112 Proheptazine 1,3-dimethyl-4-phenyl-4 propionoxyazacycloheptane 113 Properidine 1-methyl-4-phenylpiperidine-4 carboxylic acid isopropyl ester 114 Racemethorphan4 (±)-3-methoxy-N methylmorphinan 115 Racemoramide (±)-4-[2-methyl-4-oxo-3,3 diphenyl-4-(1 pyrrolidinyl)butyl]morpholine 116 Racemorphan4 (±)-3-hydroxy-N methylmorphinan 117 Remifentanil 1-(2-methoxycarbonylethyl)-4 (phenylpropionylamino) piperidine-4-carboxylic acid methyl ester 15Poisons, Opium and Dangerous Drugs (Amendment) Act, No. 41 of 2022 118 Sufentanil N-[4-(methoxymethyl)-1-[2-(2 thienyl)ethyl]-4 piperidyl]propionanilide 119 Tetrahydrofuranyl N-phenyl-N-[1 fentanyl (THF-F) (2-phenylethyl)piperidin-4 yl]tetrahydrofuran-2- carboxamide 120 Thebacon Acetyldihydrocodeinone (acetylated enol form of hydrocodone) 121 Thebaine 3,6-dimethoxy-17-methyl 6,7,8,14-tetradehydro-4,5alpha epoxymorphinan 122 Thiofentanyl N-[1-[2-(2-thienyl)ethyl]-4 piperidyl]propionanilide 123 Tilidine (±)-ethyl-trans-2-(dimethylamino) 1-phenyl-3-cyclohexene-1 carboxylate 124 Trimeperidine 1,2,5-trimethyl-4-phenyl-4 propionoxypiperidine 125 U-47700 3,4-dichloro-N-(2-dimethylamino cyclohexyl)-N-methyl-benzamide 126 Tramadol 2-[(Dimethylamino)methyl]-1-(3 methoxyphenyl)cyclohexanol 127 Pregabalin (3S)-3-(aminomethyl)-5 methylhexanoic acid 128 Gabapentine 2-[1-(Aminomethyl)cyclohexyl]acetic acid 1. The isomers, unless specifically excepted, of the dangerous drugs in this Section whenever the existence of such isomers is possible within the specific chemical designation. 2. The esters and ethers, unless appearing in another part, of the dangerous drugs in this Section whenever the existence of such esters or ethers is possible. 3. The salts of the dangerous drugs mentioned in this Section, including the salts of the isomers, whenever the formation of such salts is possible. 4. Any substance, that are substantially similar to the parent substances listed in this Section, which typically exhibiting high abuse potential. 16 Poisons, Opium and Dangerous Drugs (Amendment) Act, No. 41 of 2022 5. Any chemical analogue with modification in any of the atom of the parent substance listed in this Section by any atom or specific group of atoms (functional group), which typically exhibiting high abuse potential. 6. Substances, preparations or mixtures containing any proportion of a dangerous drug in this Section and isomers, esters and salts as specified in the paragraph 1, 2, 3, 4 and 5 above. 7. Any solution or dilution of morphine or cocaine or their salts in an inert substance whether liquid or solid containing any proportion of morphine or cocaine and any preparation, admixture, extracts, or other substances (not being such a solution or dilution as aforesaid) containing not less than 0.2 per centum of morphine or 0.1 per centum of cocaine or ecgonine. SECTION 2 1 Cannabinol and 6,6,9-Trimethyl-3 cannabinol pentyl-benzo[c]chromen-1-ol derivatives (CBN) 2 Cathinone (–)-(S)-2-aminopropiophenone 3 DET 3-[2-(diethylamino)ethyl]indole 4 DMHP 3-(1,2-dimethylheptyl)-7,8,9,10 tetrahydro-6,6,9-trimethyl-6H dibenzo[b,d]pyran- 1-ol 5 DMT 3-[2-(dimethylamino)ethyl]indole 6 DMA (±)-2,5-dimethoxy-α (2,5-Dimethoxy methylphenethylamine amphetamine) 7 DOET (±)-4-ethyl-2,5-dimethoxy-α methylphenethylamine 8 DOB (±)-4-bromo-2,5 (Brolamfetamine) dimethoxy-α methylphenethylamine 9 DOC 4-Chloro-2,5 dimethoxyamfetamine 10 Etryptamine 3-(2-aminobutyl)indole 11(+)-Lysergide and N,N-Diethyl-D-lysergamide and other substances other substances structurally structurally derived from lysergamide by derived from substitution of any of the atoms, lysergamide 12 Mescaline 3,4,5-trimethoxyphenethylamine 17Poisons, Opium and Dangerous Drugs (Amendment) Act, No. 41 of 2022 13 MDMA(3,4-Methyl (±)-N,α-dimethyl-3,4 enedioxymeth (methylenedioxy) amphetamine) phenethylamine 14 5-Methoxy-MDA 5-methoxy-α-methyl (MMDA) 3,4- (methylenedioxy) phenethylamine 15 Tenamfetamine α-methyl-3,4 (MDA) (methylenedioxy) phenethylamine 16 4-Methylaminorex (±)-cis-2-amino-4-methyl-5 phenyl-2-oxazoline 17 Methcathinone 2-(methylamino)-1-phenylpropan 1-one 18 4-Methylthio α-methyl-4 amphetamine methylthiophenethylamine (4-MTA) 19 N-Ethyl MDA (±)-N-ethyl-α-methyl (MDEA) 3,4- (methylenedioxy) phenethylamine 20 N-Hydroxy MDA (±)-N[α-methyl-3,4 (methylenedioxy) phenethyl]hydroxylamine 21 25B-NBOMe 2-(4-bromo-2,5-dimethoxyphenyl) N-(2-methoxybenzyl) ethanamine 22 25C-NBOMe 2-(4-chloro-2,5-dimethoxyphenyl) N-(2-methoxybenzyl) ethanamine 23 25I-NBOMe 2-(4-iodo-2,5-dimethoxyphenyl) N- (2-methoxybenzyl) ethanamine 24 Parahexyl 3-hexyl-7,8,9,10-tetrahydro-6,6,9 trimethyl-6H-dibenzo[b,d]pyran 1-ol 2 5 Eticyclidine (PCE) N-ethyl-1 phenylcyclohexylamine 26 Rolicyclidine 1-(1-phenylcyclohexyl) (PCPy) pyrrolidine 2 7 Psilocine (psilotsin, 3-[2 4-HO-DMT) (dimethylamino) ethyl]indol-4-ol 28 Psilocybine 3-[2-(dimethylamino)ethyl]indol 4-yl dihydrogen phosphate 29 p-Methoxyam 1-(4 phetamine (PMA) methoxyphenyl) propan-2-amine 30 p-Methoxymetham 1-(4-methoxyphenyl)-2 phetamine (PMMA) methylaminopropane 18 Poisons, Opium and Dangerous Drugs (Amendment) Act, No. 41 of 2022 31 2,5-Dimethoxy-4- 2,5-dimethoxy-α,4 methylamphetamine dimethylphenethylamine (STP, DOM) 32 Tenocyclidine (TCP) 1-[1-(2-thienyl)cyclohexyl] piperidine 33 Tetrahydro- tetrahydrocannabinol, cannabinol (THC) the following isomers and their stereochemical variants: (i) delta-6a(10a)-THC 7,8,9,10-tetrahydro-6,6,9 trimethyl-3-pentyl-6H dibenzo[b,d]pyran-1-ol (ii) delta-6a(7)-THC (9R,10aR)-8,9,10,10a-tetrahydro 6,6,9-trimethyl-3-pentyl-6H dibenzo[b,d]pyran- 1-ol (iii) delta-7-THC (6aR,9R,10aR)-6a,9,10,10a tetrahydro-6,6,9-trimethyl-3 pentyl-6H-dibenzo[b,d]pyran-1-ol (iv) delta-8-THC (6aR,10aR)-6a,7,10,10a-tetrahydro 6,6,9-trimethyl-3-pentyl-6H dibenzo[b,d]pyran-1-ol (v) delta-10-THC 6a,7,8,9-tetrahydro-6,6,9 trimethyl-3-pentyl-6H dibenzo[b,d]pyran-1-ol (vi) delta-9(11)-THC (6aR,10aR)-6a,7,8,9,10,10a hexahydro-6,6-dimethyl-9 methylene3-pentyl-6H dibenzo[b,d]pyran-1-ol 34 Trimethoxyam (±)-3,4,5- trimethoxy-α phetamine (TMA) methylphenethylamine 35 Amphetamine (±)-α-methylphenethylamine 36 Amineptine 7-[(10,11-dihydro-5H dibenzo[a,d]cyclohepten-5 yl)amino]heptanoic acid 37 AM-2201, [1-(5-Fluoropentyl)-1H-indol-3 JWH-2201 yl](naphthalen-1-yl)methanone 38 5F-APINACA, N-(adamantan-1-yl)-1 5F-AKB-48 (5-fluoropentyl)-1H-indazole-3 carboxamide 39 5F-AMB, 5F-AMB Methyl 2-({[1-(5 PINACA fluoropentyl)-1H-indazol 3yl]carbonyl}amino)-3 methylbutanoate 19Poisons, Opium and Dangerous Drugs (Amendment) Act, No. 41 of 2022 40 2C-B 4-bromo-2,5 dimethoxyphenethylamine 41 AB-CHMINACA N-[(2S)-1-amino-3-methyl oxobutan-2-yl]-1 (cyclohexylmethyl)-1H-indazole-3 carboxamide 42 CUMYL-4CN- 1-(4-cyanobutyl)-N-(2 BINACA phenylpropan-2-yl)-1H-indazole 3-carboxamide 43 ADB-CHMINACA, N-[(2S)-1- amino-3,3 MAB-CHMINACA dimethyl-1-oxobutan-2-yl] 1-(cyclohexylmethyl)-1H indazole-3-carboxamide 44 4-Chlorome 1-(4-chlorophenyl)-2 thcathinone, (methylamino)-1-propanone Clephedrone (4-CMC) 45 dexamphetamine (+)-α-methylphenethylamine 46 Dronabinol (delta (6aR,10aR)-6a,7,8,10a 9-tetrahydro- 6,6,9- trimethyl-3- pentyl-6H cannabinol and its dibenzo[b,d]pyran-1-ol stereochemical variants) 47 Ethylone (RS)-1-(1,3-Benzodioxol-5-yl)-2 (ethylamino)propan-1-one 48 Ethylphenidate ethyl 2-phenyl-2-piperidin-2 ylacetate [1] 49 Fenetylline 7-[2-[(α-methylphenethyl) amino]ethyl]theophylline 50 4-Fluoroam 1-(4-Fluorophenyl) phetamine, 4-FA propan-2-amine 51 FUB-AMB, MMB- Methyl(2S)-2-({1-[4-fluorophenyl] FUBINACA, AMB- methyl-1H- indazole-3 FUBINACA -carbonyl}amino)-3 methylbutanoate 52 ADB-FUBINACA N-[(2S)-1-amino-3,3-dimethyl-1 oxobutan-2-yl]-1-[(4 fluorophenyl)methyl]-1H indazole-3-carboxamide 53 AB-FUBINACA N-[(2S)-1-amino-3-methyl-1 oxobutan-2-yl]-1-[(4 fluorophenyl)methyl]indazole-3 carboxamide 20 Poisons, Opium and Dangerous Drugs (Amendment) Act, No. 41 of 2022 54 γ-Hydroxybutyric γ-Hydroxybutyric acid acid (GHB ACID) 55 JWH-018, AM-678 Naphthalene-1-yl(1-pentyl-1H indol-3-yl)methanone 56 Ketamine 2-(Methylamino)-2-(2 chlorophenyl)cyclohexanone 57 Levamphetamine (–)-(R)-α-methylphenethylamine (amphetamine(-) isomer 58 Levometham (–)-N,α-dimethylphenethylamine phetamine 59 Mecloqualone 3-(o-chlorophenyl)-2-methyl 4(3H)-quinazolinone 60 Methamphetamine (+)-(S)-N,α (Methylamphetamine) dimethylphenethylamine 61 Methaqualone 62 Methylphenidate 63 Methamphetamine racemate 64 3,4-Methylenedioxy 2-methyl-3-o-tolyl-4(3H) quinazolinone methyl α-phenyl-2-piperidine acetate (±)-N,α-dimethylphenethylamine (RS)-1-(Benzo[d][1,3]dioxol-5 pyrovalerone(MDPV) yl)-2- (pyrrolidin-1 yl)pentan-1-one 65 Mephedrone, 4- (RS)-2-methylamino-1-(4 methylmethcathinone methylphenyl)propan-1-one 66 Methylone, (RS)-2-methylamino-1-(3,4 (beta-keto-MDMA) methylenedioxyphenyl) propan 1-one 67 Methoxetamine (RS)-2-(3-methoxyphenyl)-2 (MXE) (ethylamino)-cyclohexanone 68 MDMB-CHMICA methyl 2-[[1-(cyclohexylmethyl) indole-3-carbonyl]amino] 3,3dimethylbutanoate 69 Methiopropamine 1-(thiophen-2-yl)-2 (MPA) methylaminopropane 70 4-methylethcathinone 2-(Ethylamino)-1-(4 (4-MEC) methylphenyl) propan-1-one 71 5F-MDMB-PICA Methyl(S)-2-(1-(5-fluoropentyl)-1H indole-3-carboxamido)-3,3 dimethylbutanoate 21Poisons, Opium and Dangerous Drugs (Amendment) Act, No. 41 of 2022 72 4F-MDMB-BINACA Methyl(S)-2-(1-(4-fluorobutyl) 1H-indazole-3-carboxamido)-3,3 dimethylbutanoate 73 N-Benzylpiperazine 1-benzylpiperazine (BZP) 74 N-Ethylnorpentylone 1-(2H-1,3-benzodioxol-5-yl)-2 (ethylamino)pentan-1-one 75 N-Ethylhexedrone 2-(Ethylamino)-1-phenyl-1 hexanone 76 Phencyclidine (PCP) 1-(1-phenylcyclohexyl) piperidine 77 Phenmetrazine 3-methyl-2-phenylmorpholine 78 5F-ADB, 5F-MDMB Methyl(2S)-2-{[1 PINACA (fluoropentyl)-1H-indazole-3 carbonyl] amino}-3,3 dimethylbutanoate 79 AB-PINACA N-[(2S)-1-Amino-3-methyl-1 oxobutan-2-yl]-1-pentyl-1H indazole-3-carboxamide 80 alpha-PVP α-pyrrolidinovalerophenone 81 4,4’-dimethylaminorex para-methyl (4,4’-DMAR) 4-methylaminorex 82 Pentedrone (±)-2-(methylamino)-1 phenylpentan-1-one 83 5F-PB-22 Quinolin-8-yl 1-(5-fluoropentyl) 1H-indole-3-carboxylate 84 alpha-PHP (RS)-1-Phenyl-2-(pyrrolidine-1 yl)hexan-1-one 85 Secobarbital 5-allyl-5-(1 methylbutyl)barbituric acid 86 UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3 tetramethylcyclopropoyl) methanone 87 XLR-11 [1-(5-Fluoropentyl)-1H-indol-3-yl] (2,2,3,3tetramethylcyclopropyl) methanone 88 Zipeprol α-(α-methoxybenzyl)-4-(α methoxyphenethyl)-1 piperazineethanol 89 Amobarbital 5-ethyl-5-isopentylbarbituric acid 90 Butalbital 5-allyl-5-isobutylbarbituric acid 22 Poisons, Opium and Dangerous Drugs (Amendment) Act, No. 41 of 2022 91 Buprenorphine 2l-cyclopropyl-7-α-[(S)-1-hydroxy 1,2,2-trimethylpropyl]-6,14-endo ethano- 6,7,8,14 tetrahydrooripavine 92 Cyclobarbital 5-(1-cyclohexen-1-yl)-5 ethylbarbituric acid 93 (+)-Norpseudoe 2-amino-1-hydroxy-1 phedrine -phenylpropane (including Cathine) 94 Flunitrazepam 5-(o-fluorophenyl)-1,3-dihydro-1 methyl-7-nitro-2H-1,4 benzodiazepin-2-one 95 Glutethimide 2-ethyl-2-phenylglutarimide 96 Pentobarbital 5-ethyl-5-(1 methylbutyl)barbituric acid 97 Pentazocine (2R*,6R*,11R*)-1,2,3,4,5,6 hexahydro-6,11-dimethyl-3-(3 methyl-2-butenyl)-2,6- methano-3 benzazocin-8-ol 98 diethylpropion 2-(diethylamino)propiophenone 99 Alprazolam 8-chloro-1-methyl-6-phenyl-4H-s triazolo[4,3-a][1,4] benzodiazepine 100 Allobarbital 5,5-diallylbarbituric acid 101 Aminorex 2-amino-5-phenyl-2-oxazoline 102 Barbital 5,5-diethylbarbituric acid 103 Benzphetamine N-benzyl-N,α dimethylphenethylamine 104 Bromazepam 7-bromo-1,3-dihydro-5-(2 pyridyl)-2H-1,4- benzodiazepin-2 one 105 Butobarbitone 5-butyl-5 (Butobarbital) ethylbarbituricacid 106 Brotizolam 2-bromo-4-(o- chlorophenyl) -9 methyl- 6H-thieno[3,2-f]-s triazolo[4,3- a][1,4]diazepine 107 Camazepam 7-chloro-1,3-dihydro-3-hydroxy-1 methyl-5-phenyl- 2H-1,4 benzodiazepin-2-one dimethylcarbamate (ester) 108 Chlordiazepoxide 7-chloro-2-(methylamino)-5 phenyl-3H-1,4- benzodiazepine-4 oxide 23Poisons, Opium and Dangerous Drugs (Amendment) Act, No. 41 of 2022 109 Clobazam 7-chloro-1-methyl-5-phenyl-1H 1,5-benzodiazepine- 2,4(3H,5H) dione 110 Clonazepam 5-(o-chlorophenyl)-1,3-dihydro-7 nitro-2H-1,4- benzodiazepin-2-one 111 Clorazepate 7-chloro-2,3-dihydro-2-oxo-5 phenyl-1H-1,4- benzodiazepine-3 carboxylic acid 112 Clotiazepam 5-(o-chlorophenyl)-7-ethyl-1,3 dihydro-1-methyl-2H- thieno[2,3 e]-1,4-diazepin- 2-one 113 Cloxazolam 10-chloro-11b-(o-chlorophenyl) 2,3,7,11b-tetrahydro- oxazolo [3,2-d][1,4]benzodiazepin-6(5H) one 114 Delorazepam 7-chloro-5-(o-chlorophenyl)-1,3 dihydro-2H-1,4- benzodiazepin-2 one 115 Diazepam 7-chloro-1,3-dihydro-1-methyl-5 phenyl-2H-1,4- benzodiazepin-2 one 116 Ethchlorvynol 1-chloro-3-ethyl-1-penten-4-yn-3 ol 117 Ethinamate 1-ethynylcyclohexanolcarbamate 118 Estazolam 8-chloro-6-phenyl-4H-s-triazolo[4,3 a][1,4]benzodiazepine 119 Ethyl loflazepate ethyl 7-chloro-5-(o-fluorophenyl) 2,3-dihydro-2-oxo- 1H-1,4 benzodiazepine-3- carboxylate 120 N-ethylamphetamine N-ethyl-α-methylphenethylamine 121 Etizolam 4-(2-Chlorophenyl)-2-ethyl-9-methyl 6H-thieno[3,2-f][1,2,4] triazolo [4,3a][1,4] diazepine 122 Fludiazepam 7-chloro-5-(o-fluorophenyl)-1,3 dihydro-1-methyl-2H- 1,4 benzodiazepin-2-one 123 Flurazepam 7-chloro-1-[2-(diethylamino)ethyl]-5 (o-fluorophenyl)- 1,3-dihydro-2H-1,4 benzodiazepin-2-one 124 Fencamfamin N-ethyl-3-phenyl-2 norbornanamine 24 Poisons, Opium and Dangerous Drugs (Amendment) Act, No. 41 of 2022 125 Fenproporex (±)-3-[(α-methylphenylethyl) amino]propionitrile 126 Flualprazolam 8-Chloro-6-(2-fluoro-phenyl)-1 methyl-4h- benzo[f][1,2,4]triazolo[4,3 a][1,4] diazepime 127 Halazepam 7-chloro-1,3-dihydro-5-phenyl-1 (2,2,2-trifluoroethyl)- 2H-1,4 benzodiazepin-2-one 128 Haloxazolam 10-bromo-11b-(o-fluorophenyl) 2,3,7,11b- tetrahydrooxazolo[3,2-d] [1,4]benzodiazepin- 6(5H)-one 129 Ketazolam 11-chloro-8,12b-dihydro-2,8 dimethyl-12b-phenyl-4H [1,3]oxazino[3,2 d][1,4]benzodiazepin-4,7(6H) dione 130 Lefetamine (SPA) (–)-N,N-dimethyl-1,2 diphenylethylamine 131 Loprazolam 6-(o-chlorophenyl)-2,4-dihydro-2 [(4-methyl-1 piperazinyl)methylene]-8-nitro 1H-imidazo[1,2 a][1,4]benzodiazepin-1-one 132 Lorazepam 7-chloro-5-(o-chlorophenyl)-1,3 dihydro-3-hydroxy-2H- 1,4 benzodiazepin-2-one 133 Lormetazepam 7-chloro-5-(o-chlorophenyl)-1,3 dihydro-3-hydroxy-1- methyl-2H 1,4- benzodiazepin-2-one 134 Mazindol 5-(p-chlorophenyl)-2,5-dihydro 3H-imidazo[2,1-a]isoindol-5-ol 135 Meprobamate 2-methyl-2-propyl-1,3 propanedioldicarbamate 136 Methylphenobarbital 5-ethyl-1-methyl-5 phenylbarbituric acid 137 Methyprylon 3,3-diethyl-5-methyl-2,4 piperidine-dione 138 Medazepam 7-chloro-2,3-dihydro-1-methyl-5 phenyl-1H-1,4- benzodiazepine 139 Mefenorex N-(3-chloropropyl)-α methylphenethylamine 25Poisons, Opium and Dangerous Drugs (Amendment) Act, No. 41 of 2022 140 Midazolam 8-chloro-6-(o-fluorophenyl)-1 methyl-4H- imidazo[1,5 a][1,4]benzodiazepine 141 Mesocarb 3-(α-methylphenethyl)-N (phenylcarbamoyl)sydnone imine 142 Nimetazepam 1,3-dihydro-1-methyl-7-nitro-5 phenyl-2H-1,4-benzodiazepin-2 one 143 Nitrazepam 1,3-dihydro-7-nitro-5-phenyl-2H 1,4-benzodiazepin-2-one 144 Nordazepam 7-chloro-1,3-dihydro-5-phenyl 2H-1,4-benzodiazepin-2-one 145 Oxazepam 7-chloro-1,3-dihydro-3-hydroxy 5-phenyl-2H-1,4-benzodiazepin 2-one 146 Oxazolam 10-chloro-2,3,7,11b-tetrahydro-2 methyl-11b-phenyloxazolo[3,2 d][1,4]benzodiazepin- 6(5H)-one 147 Phendimetrazine (+)-(2S,3S)-3,4-dimethyl-2 phenylmorpholine 148 Phenobarbital 5-ethyl-5-phenylbarbituric acid 149 Phentermine α,α-dimethylphenethylamine 150 Pipradrol 1,1-diphenyl-1-(2-piperidyl) methanol 151 Pinazepam 7-chloro-1,3-dihydro-5-phenyl-1 (2-propynyl)-2H- 1,4 benzodiazepin-2-one 152 Prazepam 7-chloro-1-(cyclopropylmethyl)-1,3 dihydro-5- phenyl-2H-1,4 benzodiazepin-2- one 153 Pyrovalerone 4’-methyl-2-(1 pyrrolidinyl) valerophenone 154 Pemoline 2-amino-5-phenyl-2-oxazolin-4 one 155 Phenazepam 7-bromo-5-(2-chlorophenyl) (Fenazepam) -1,3-dihydro-2H 1,4- benzodiazepin-2-one 156 Secbutabarbital 5-sec-butyl-5-ethylbarbituric acid 157 Temazepam 7-chloro-1,3-dihydro-3-hydroxy 1-methyl-5-phenyl- 2H-1,4 benzodiazepin-2-one 26 Poisons, Opium and Dangerous Drugs (Amendment) Act, No. 41 of 2022 158 Tetrazepam 7-chloro-5-(1-cyclohexen-1-yl)-1,3 dihydro-1- methyl-2H-1,4 benzodiazepin-2- one 159 Triazolam 8-chloro-6-(o-chlorophenyl)-1 methyl-4H-s- triazolo[4,3- a][1,4] benzodiazepine 160 Vinylbital 5-(1-methylbutyl)-5-vinylbarbituric acid 161 Zolpidem N,N,6-trimethyl-2-p-tolylimidazo [1,2-a]pyridine-3-acetamide 1. The isomers, unless specifically excepted, of the drugs in this Section whenever the existence of such isomers is possible within the specific chemical designation. 2. The esters and ethers, unless appearing in another part, of the drugs in this Section whenever the existence of such esters or ethers is possible. 3. The salts of the dangerous drugs mentioned in this Section, including the salts of the isomers, whenever the formation of such salts is possible. 4. Any substance, that are substantially similar to the parent substances listed in this Section, which typically exhibiting high abuse potential. 5. Any chemical analogue with modification in any of the atom of the parent substance listed in this Section by any atom or specific group of atoms (functional group), which typically exhibiting high abuse potential. 6. Substances, preparations or mixtures containing any proportion of drug/drugs in this Section and isomers, esters and salts as specified in the paragraphs 1, 2, 3, 4 and 5 above. SECTION 3 The groups of substances, including any salt or sterioisomeric form of such substances and any preparation, mixture or a product containing such substances as indicated below:– 1. Amphetamine analogues, other than listed in the above Section 2, in which the 1-amino-2- phenylethane nucleus carries any of the following substituent, either alone or in combination:– (a) 1 or 2 alkyl substituents, each with up to 6 carbon atoms, attached to the nitrogen atom; 27Poisons, Opium and Dangerous Drugs (Amendment) Act, No. 41 of 2022 (b) 1 or 2 methyl substituents or an ethyl substituent, attached to the carbon atom adjacent to the nitrogen atom; (c) a hydroxy substituent attached to the carbon atom adjacent to the benzene ring; (d) any combination of up to 5 alkyl substituent and/or alkoxy substituent and/or alkylamino substituent and/ or alkylthio substituent (each with up to 6 carbon atoms, including cyclic substituent) and/or halogen substituent and/or nitro substituent and/or amino substituent, attached to the benzene ring. 2. Pethidine analogues, in which any substance (not being listed in above Section 1) structurally derived from pethidine (4-phenylpiperidine nucleus) by modification in any of the atom by any atom or specific group of atoms (functional group) or stereoisomeric form of any such substance, any preparation or product containing any such substance and thereof, any of the following ways: (a) by replacement of the 1-methyl group by an acyl, alkyl whether or not unsaturated, benzyl or phenethyl group, whether or not further substituted; (b) by substitution in the piperidine ring with alkyl or alkenyl groups or with a propano bridge, whether or not further substituted; (c) by substitution in the 4-phenyl ring with alkyl, alkoxy, aryloxy, halogen or haloalkyl groups; (d) by replacement of the 4-ethoxycarbonyl by any other alkoxycarbonyl or any alkoxyalkyl or acyloxy group; (e) by formation of an N-oxide or of a quaternary base. 3. Phencyclidine analogues, any substance other than listed in the above Section 2, being chemical substances with the 1-alkylamino-1-arylcyclohexane (arylcycloalkylamines) structure, with any combination of the followings: (a) t h e a l k y l a m i n o s u b s t i t u e n t i s 1 - p i p e r i d i n y l , 1-pyrrolidinyl, 4-morpholinyl, or any other substituent with up to 6 carbon atoms in the alkyl portion; (b) the aryl substituent is phenyl, thienyl, pyridinyl, or pyrrolidinyl; 28 Poisons, Opium and Dangerous Drugs (Amendment) Act, No. 41 of 2022 (c) the aryl substituent, carries any combination of up to 5 alkyl substituents and/or alkoxy substituent (each with up to 6 carbon atoms, including cyclic substituents) and/or halogen substituents; (d) any related substances, including any salt or stereoisomeric form of such substances, and any preparation or product containing such substances. 4. Fentanyl analogues, any substance other than listed in above Section 1, in which the N-[1-(2- phenethyl)-4-piperidyl]aniline nucleus has additional substituents, either alone or in combination or by any modification attached as follows: (a) by replacement of the phenyl portion of the phenethyl group by any heteromonocycle whether or not further substituted in the heterocycle; (b) by substitution in the phenethyl group with alkyl, alkenyl, alkoxy, hydroxy, halogen, haloalkyl, amino or nitro groups; (c) by substitution in the piperidine ring with alkyl or alkenyl groups; (d) by substitution in the aniline ring with alkyl, alkoxy, alkylenedioxy, halogen or haloalkyl groups; (e) by substitution at the 4-position of the piperidine ring with anyalkoxycarbonyl or alkoxyalkyl or acyloxy group; (f) by replacement of the N-propionyl group by another acyl group; or (g) any substances (other than a substance listed in Section 1), structurally derived from (1-Methyl- 4-piperidyl) N-phenylformamide by any substitution and thereof. 5. Methaqualone analogues, any substance other than listed in the above Section 2, in which the 3- arylquinazolin-4-one nucleus has additional substituents, either alone or in combination, attached as follows:– (a) an alkyl substituent, with up to 6 carbon atoms, attached at the 2 position; 29Poisons, Opium and Dangerous Drugs (Amendment) Act, No. 41 of 2022 (b) any combination of up to 5 alkyl substituents and/or alkoxy substituents (each with up to 6 carbon atoms, including cyclic substituents) and/or halogen substituents, attached to each of the aryl rings. 6. Tryptamines analogues, which any substance (other than a substance listed in the above Section 2 or serotonin) structurally derived from 2-(1Hindol-3-yl) ethanamine (tryptamine) or from a ring- hydroxy by modification in any of the atom by any atom or specific group of atoms (functional group), including any ether, salt or stereoisomeric form of any such substance, any preparation or product containing any such substance and thereof, such as (a) by substitution at the nitrogen atom of the side chain to any extent with alkyl or alkenyl substituents or by inclusion of the nitrogen atom of the side chain (and no other atoms of the side chain) in acyclic structure; (b) by substitution at the carbon atom adjacent to the nitrogen atom of the side chain with alkyl or alkenyl substituents; (c) by substitution in the 6-membered ring to any extent with alkyl, alkoxy, haloalkyl, thioalkyl, alkylenedioxy, or halide substituents; (d) by substitution at the 2-position of the tryptamine ring system with an alkyl substituent. 7. Synthetic Cathinones and their analogues. Any substance, (other than a substance listed in the above Section 2 or bupropion) that is structurally derived from 2- amino-1-phenylpropan-1-one by modification in any of the atom by any substitution by an atom or a specific group of atoms (functional group) or substituent including any salt or stereoisomeric form thereof, and any preparation or product containing thereof. 8. Aminodanes and their analogues. Any aminodane (other than listed in the above Sections) and any substance, including any salt or stereoisomeric form of such substances, and any preparation or product containing such substances. 30 Poisons, Opium and Dangerous Drugs (Amendment) Act, No. 41 of 2022 9. Phenethylamines and their analogues. Any phenethylamine substance (other than a substance listed in the above Section 2), including any type of positional isomer in the phenyl ring by modification in any of the atom by any substitution by an atom or a specific group of atoms (functional group), substituted substances such as the ‘2C series’, ring substituted amphetamines such as the ‘D series’, any benzodifurans or its substituent and any others substance thereof, including any salt or stereoisomeric form thereof, and any preparation or product containing thereof. 10. Any substance (not being bupropion, cathinone, diethylpropion, pyrovalerone or not being listed for the time being specified in above Sections) structurally derived from 2–amino–1–phenyl– 1– propanone by modification in any of the following ways, that is to say (a) by substitution in the phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl or halide substituents, whether or not further substituted in the phenyl ring by one or more other univalent substituents; (b) by substitution at the 3–position with an alkyl substituent; (c) by substitution at the nitrogen atom with alkyl or dialkyl groups, or by inclusion of the nitrogen atom in a cyclic structure. 11. Any substance (other than a substance listed in above Sections) structurally derived from 2– aminopropan–1–one by substitution at the 1-position with any monocyclic or fused polycyclic ring system or not being listed for the time being specified in above Sections or not being a phenyl ring or alkylenedioxyphenyl ring system), whether or not the substance is further modified in any of the following ways, that is to say (a) by substitution in the ring system to any extent with alkyl, alkoxy, alkylenedioxy haloalkyl or halide substituents, whether or not further substituted in the ring system by one or more other univalent substituents; (b) by substitution at the 3–position with an alkyl substituent; (c) by substitution at the 2-amino nitrogen atom with alkyl or dialkyl groups, or by inclusion of the 2-amino nitrogen atom in a cyclic structure. 31Poisons, Opium and Dangerous Drugs (Amendment) Act, No. 41 of 2022 12. Any substance (not being listed in above Sections or not being pipradrol) structurally derived from piperidine, pyrrolidine, azepane, morpholine or pyridine by substitution at a ring carbon atom with a diphenylmethyl group, whether or not the substance is further modified in any of the following ways, that is to say (a) by substitution in any of the phenyl rings to any extent with alkyl, alkoxy, haloalkyl or halide groups; (b) by substitution at the methyl carbon atom with an alkyl, hydroxyalkyl or hydroxy group; (c) by substitution at the ring nitrogen atom with an alkyl, alkenyl, haloalkyl or hydroxyalkyl group. 13. Any substance falls into the category of “Synthetic Cannabinoids” (other than listed in above Section 2), any salt or stereoisomeric form of such substances, and any preparation or product containing such substances:– (a) Any substance other than listed in above Section 2, containing a 3-(1-naphthylmethyl)indole structure with substitution at the nitrogen atom of the indole ring by an atom or any specific group of atoms (functional group), and any derivatives of the above substances including any salt or stereoisomeric form of the above substances or derivatives, and any preparation or product containing the above substances or derivatives; (b) Any substance other than listed in above Section 2, containing a 3-(1-naphthoyl)pyrrole structure with substitution at the nitrogen atom of the pyrrole ring by an atom or any specific group of atoms (functional group), and any derivatives of the above substances containing functional groups, including any salt or stereoisomeric form of the above substances or derivatives, and any preparation or product containing the above substances or derivative; (c) Any substance other than listed in above Section 2, containing a naphthylideneindene structure with any substitution at any position of the indene ring by an atom or any specific group of atoms (functional group), and any derivatives of the above substances containing hydroxy and/or carboxylic acid groups, including any salt or stereoisomeric form of the above substances or derivatives, and any preparation or product containing the above substances or derivatives; 32 Poisons, Opium and Dangerous Drugs (Amendment) Act, No. 41 of 2022 (d) Any substance other than listed in above Section 2, containing a 2-(3-hydroxycyclohexyl)phenol structure with substitution at any position of the phenolic ring by an atom or any specific group of atoms (functional group), and any derivatives of the above substances containing hydroxy and/or carboxylic acid groups, including any salt or stereoisomeric form of the above substances or derivatives, and any preparation or product containing the above substances or derivatives. 14. The analogues gamma-Hydroxybutyrate (GHB) and— (a) the esters, ethers, and amides of GHB; and (b) all substances from which GHB can be derived, including (without limitation)— (i) 1,4-butanediol; (ii) gamma-aminobutyric acid; (iii) gamma-butyrolactone; (iv) gamma-hydroxybutyraldehyde; and (c) the salts of GHB (including sodium oxybate) and the salts of any substance referred to in paragraph (a) or paragraph (b); and (d) any substance, preparation, or mixture containing any proportion of GHB or any substance referred to in any of paragraphs (a) to (c). 15. Plant based substances causing a psychoactive effect Any part of the plant other than listed in above Sections 1 and 2, any extract or preparation thereof of the following plants:– (a) Khat (Catha edulis); (b) Kratom (Mitragyna speciosa); (c) Salvia (Salvia divinorum); (d) Chacruna (Psychiotria viridis); (e) Mimosa hostilis (Mimosa tenuiflora); 33Poisons, Opium and Dangerous Drugs (Amendment) Act, No. 41 of 2022 (f) Hawaiian Baby Woodrose (Argyreia nervosa); (g) Iboga (Tabernanthe iboga), or any other plant containing any dangerous drug or a substance substantially similar to dangerous drugs or an substituted analogue of a dangerous drug listed in above Sections 1 and 2, which typically exhibiting high abuse potential.”. (2) by the repeal of Part III of that Schedule and the substitution therefor of the following Part: “PART III (section 54A) PART III Column I Column II Column III Nature of Pure Quantities Penalty Offences Traffics, Opium possess, imports or exports do- 1 kilogramme or above do- 500 grammes to less than 1 kilogramme do- 50 grammes to less than 500 grammes do- 10 grammes to less than 50 grammes Fine not less than One Hundred Thousand Rupees and not exceeding Two Hundred Thousand Rupees and imprisonment of either description for a period not less than five years and not exceeding ten years or to both such fine and imprisonment. Fine not less than Two Hundred Thousand Rupees and not exceeding Five Hundred Thousand Rupees and imprisonment of either description for a period not less than ten years and not exceeding fifteen years or to both such fine and imprisonment. Death or life imprisonment. Life imprisonment. 34 Poisons, Opium and Dangerous Drugs (Amendment) Act, No. 41 of 2022 do- Less than 10 grammes Morphine, Cocaine, Heroin and Methamphetamine do- 5 grammes or Death or life imprisonment. above 3 grammes to less than 5 grammes 2 grammes to less than 3 grammes Less than 2 grammes Cannabis 100 kilogrammes or above Fine not less than Two Hundred Thousand Rupees and not exceeding Five Hundred Thousand Rupees and imprisonment of either description for a period not less than ten years and not exceeding twenty years or to both such fine and imprisonment. Fine not less than One Hundred Thousand Rupees and not exceeding Two Hundred Thousand Rupees and imprisonment of either description for a period not less than seven years and not exceeding ten years or to both such fine and imprisonment. Fine not less than Twenty Five Thousand Rupees and not exceeding Fifty Thousand Rupees and imprisonment of either description for a period not less than three years and not exceeding five years or to both such fine and imprisonment. Fine not less than Two Hundred Thousand Rupees and not exceeding Five Hundred Thousand Rupees and imprisonment of either description for a period not less than ten years and not exceeding fifteen years or to both such fine and imprisonment. do do do do Fine not exceeding One Hundred Thousand Rupees and imprisonment of either description for a period not less than two years and not exceeding five years or to both such fine and imprisonment. 35Poisons, Opium and Dangerous Drugs (Amendment) Act, No. 41 of 2022 5 kilogrammes to less than 100 kilogrammes 1 kilogramme to less than 5 kilogrammes Less than 1 kilogramme 7. For the avoidance of doubt, it is hereby declared that the provisions of section 6 shall not apply in respect of an offence which was committed prior to the date of coming into operation of this Act. 8. In the event of any inconsistency between the Sinhala and Tamil texts of this Act, the Sinhala text shall prevail. Avoidance of doubt Sinhala text to prevail in case of inconsistency Fine not less than One Hundred Thousand Rupees and not exceeding Two Hundred Thousand Rupees and imprisonment of either description for a period not less than five years and not exceeding ten years or to both such fine and imprisonment. Fine not less than Fifty Thousand Rupees and not exceeding One Hundred Thousand Rupees and imprisonment of either description for a period not less than two years and not exceeding five years or to both such fine and imprisonment. Fine not less than Twenty Thousand Rupees and not exceeding Fifty Thousand Rupees and imprisonment of either description for a period not less than one year and not exceeding two years or to both such fine and imprisonment. do do do 36 Poisons, Opium and Dangerous Drugs (Amendment) Act, No. 41 of 2022 English Acts of the Parliament can be purchased at the “PRAKASHANA PIYASA”, DEPARTMENT OF GOVERNMENT PRINTING, NO. 118, DR. DANISTER DE SILVA MAWATHA, COLOMBO 8.